Celestial Biolabs Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2015. For the quarter, the company reported sales of INR 70.082 million compared to INR 76.690 million a year ago. Profit from operations before other income finance costs and exceptional items was INR 9.490 million compared to INR 9.569 million a year ago. Profit from ordinary activities before tax was INR 6.246 million compared to INR 4.412 million a year ago. Profit from ordinary activities after tax was INR 3.596 million compared to INR 4.721 million a year ago. Net profit for the period was INR 5.090 million compared to INR 3.596 million a year ago. Basic and diluted earnings per share were INR 0.27 compared to INR 0.21 a year ago.

For the nine months, the company reported sales of INR 235.257 million compared to INR 222.761 million a year ago. Profit from operations before other income finance costs and exceptional items was INR 29.224 million compared to INR 25.718 million a year ago. Profit from ordinary activities before tax was INR 16.339 million compared to INR 12.047 million a year ago. Profit from ordinary activities after tax was INR 9.819 million compared to INR 9.672 million a year ago. Net profit for the period was INR 13.315 million compared to INR 9.819 million a year ago. Basic and diluted earnings per share were INR 0.72 compared to INR 0.57 a year ago.